Alembic gets USFDA nod for generic cancer treatment medication

Alembic gets USFDA nod for generic cancer treatment medication The company has received approval from the US Food and Drug Administration (USFDA) to market its product which is a generic version of Hikma Pharmaceuticals USA Inc product, Alembic Pharmaceuticals said in a statement.

from Moneycontrol Business News https://ift.tt/fhxUNL0

No comments:

Post a Comment

Start-up Street: Social justice and the start-up ecosystem

Disparities in start-ups are a global phenomenon and affirmative action is needed to ensure an equal opportunities environment for aspiring...